![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/47 | |
C07K 14/705 | |||
A61K 39/00 | |||
A61P 35/00 | |||
C07K 14/74 |
(11) | Number of the document | 2089423 |
(13) | Kind of document | T |
(96) | European patent application number | 07827143.4 |
Date of filing the European patent application | 2007-09-23 | |
(97) | Date of publication of the European application | 2009-08-19 |
(45) | Date of publication and mention of the grant of the patent | 2016-10-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IL2007/001168 |
Date | 2007-09-23 |
(87) | Number | WO 2008/035350 |
Date | 2008-03-27 |
(30) | Number | Date | Country code |
846087 P | 2006-09-21 | US |
(72) |
CARMON, Lior, IL
|
(73) |
Vaxil Biotherapeutics Ltd.,
Building 13A Weizmann Science Park, 76120 Rehovot,
IL
|
(54) | ANTIGEN SPECIFIC MULTI EPITOPE VACCINES |
ANTIGEN SPECIFIC MULTI EPITOPE VACCINES |